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1. Introduction 
It has been well documented that the ATPase 
activity is associated with oxidative phosphorylation. 
Lately, it has become obvious that the enzyme is 
normally part of the biological membrane and is 
the terminal enzyme in the energy coupling reactions 
[l-3]. 
Evidence for the participation of non-heme iron 
proteins as functional components in the electron 
transport chain has been firmly established, but 
there is little evidence for the direct involvement 
of these proteins in energy coupling or phosphoryla- 
tion. In electron transport systems from Mycobacte- 
rium-phlei and rat liver mitochondria Kurup et al. [4] 
and Palmer [ 51 respectively have shown that the 
uncoupling effect of metal chelating agents can be 
reversed by adding ferrous ion. From the study of 
beef heart submitochondrial particles, Vallin et al. 
[6,7] and Butdw and Racker [8] proposed models 
for respiratory control correlated to oxidative 
phosphorylation through non-heme iron proteins. 
Recently, Phelps et al. [9,10] have presented experi- 
mental evidence that metalproteins act as common 
functional intermediates for both electron transport 
and energy conserving reactions of beef heart mito- 
chondria. 
Bathophenanthroline (4,7-diphenyl-I ,lO-phenan- 
throline), which is a lipophilic metal chelating agent 
also provides a useful tool for the study of the same 
phenomenon in a prokaryotic system. in this paper 
we show that bathophenanthroline inhibits E. coli 
membrane bound ATPase activity as completely as 
that of eukaryotic organelles and at similar concen- 
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tration. Uncouplers reverse the inhibition. This kind 
of inhibition is not observed in high Mg” buffer with 
the soluble ATPase. Since bathophenanthroline has 
a high affinity for ferrous ircn, we propose that a 
buried non-heme iron protein functions at a site in 
the membrane which controls the activity of the 
ATPase and therefore suggest he direct involvement 
of this protein in the energy conserving system. 
The experiments of Abrams and Baron [ 1 l] 
suggest hat the potency of N,N’-dicyclohexyl- 
carbodiimide (DCCD) is due to the ability of DCCD 
to penetrate a highly hydrophobic environment. 
This together with the fact that the DCCD binding 
protein (“10 000 dalton) is a proteolipid [ 121, 
indicates that this protein is normally also deep 
buried in the membrane. Since our results show 
that DCCD does not reverse bathophenanthroline 
inhibition, that the uncoupler carbonyl cyanide3- 
chlorophenyl hydrazone (CCCP) does not reverse 
DCCD inhibition, and DCCD inhibits the ATPase 
activity restored by CCCP in the presence of 
bathophenanthroline, we conclude that the DCCD 
binding protein is different from the bathophenan- 
throline sensitive component. 
2. Materials and methods 
The medium used for the growth of E. coli strain 
K12 wild type was that described by Monod et al. as 
medium 56 [ 131. The strain AN236 (ilv; arg; purE, 
thi-), AN283 (arg-, entA; uncb-), AN259 (arg; 
entA-) and AN293 (arg; thi; ubiB_) were provided 
by Dr F. Gibson and were grown in a manner des- 
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cribed by Cox et al. [ 141. The appropriate L-amino 
acids were added to the sterilized mineral-salt base to 
give a final concentration of 0.2 mM, thiamine and 
adenine were added to a final concentration of 0.2 
PM. The carbon source was added as a sterile solution 
at a final concentration of 30 mM. A freshly prepared 
slant was used to inoculate 700 ml of the same medium 
in 2 liter flasks which are then incubated overnight 
at 37°C on a rotary shaker. 
Cells were harvested by centrifugation at 27 000 g 
for 10 min, washed in cold 0.25 M sucrose-O.1 M 
phosphate buffer pH 7.0 and collected again by 
centrifugation at the same speed, the suspended in 
sucrose-phosphate buffer (0.5 g cell/ml.). 
Membrane fraction was prepared by disruption of 
cells by sonication with a Bronson sonifier at 7-9 
A for 3 min in ice. The cell extract was centrifuged at 
27 OOOg for 20 min and the supernatant fraction was 
then centrifuged at 100 000 g for 2 hr. The resulting 
gelatinous yellow pellet was suspended in a minimal 
volume of 0.1 M phosphate buffer pH 7.0. This sus- 
pension was designed as the membrane fraction. 
Soluble ATPase was made according to Cox et al. 
[ 141 by low ionic stength treatment with more 
extensive washings. Trypsin treatment was performed 
as described by Nieuwenhuis et al. [ 151. 
Protein was determined by the biuret method 
[ 161 with bovine serum albumin as a standard. 
The ATPase activity was measured according to 
Phelps and Crane [9] at 3O’C. This assay contains 
0.5 mM ATP and 11 .S mM Mg”. For low Mg” 
conditions the assay contained 0.1 M Tris-HCl, 2 mM 
ATP, 2 mM MgClz , 1 mM DTT, pH 8.9. Pi was 
measured by the Lindberg and Ernster procedure [ 171. 
3. Results and discussion 
Bathophenanthroline, a lipophilic chelator inhibits 
E. coli K12 membrane bound ATPase activity as 
shown in fig. 1. 40 pg (0.12 pmol) of bathophenan- 
troline is able to cause maximum inhibition (70%). 
This concentration is higher than found for mito- 
chondria where 20 pg (0.06 pmol) gives maximum 
inhibition [9]. The chelator specificity is shown in 
table 1. Orthophenanthroline (1 pmol) and a,cr’-di- 
pyridyl(0.26 E.tmol) show less than 10% and 15% 
inhibition respectively. Hydrophilic chelators such as 
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Fig.1. The inhibition of E. coli K12 membrane bound ATPase 
activity by bathophenanthroline. (0) Rate of ATP hydrolysis 
(nmoles Pi/mg protein/min); (A) percent of inhibition. Protein 
concentration was 0.37 mg for the experiment. 
bathophenanthroline sulfonate show essentially no 
inhibition. The complete lack of effects with batho- 
phenanthroline sulfonate, and minor effects with 
orthophenanthroline and a,cu’-dipyridyl indicate that 
the bathophenanthroline sites or the coupling sites 
are protected by a hydrophobic environment. The 
lack of a dithizone site contrasts with mitochondria 
where dithizone, a Cu chelator, inhibits cytochrome 
oxidase [lo]. 4,4,4-trifluoro-l-(2-thienyl)-1,3-buta- 
nedione (TTFA), a powerful metal-chelating agent, 
has been shown to be a potent inhibitor of succinate 
oxidation in mitochondria [ 181, the mechanism of 
Table 1 
The inhibition of E. coli K12 membrane-bound ATPase 
activity by various chelating agents 
Chelating agents Percent of 
inhibition 
0.12 pmol Bathophenanthroline 70 
0.77 ,umol Dithizone 0 
0.37 rmol Bathophenanthroline sulfonate 0 
1 Nmol Orthophenanthroline 9.2 
0.26 rmol a,a’-dipridyl 13.2 
0.045 wmol TTFA 31 
0.2 crmol FTFA 32 
TTFA, 4,4,4-trifluoro-l-(2-thienyl)-1,3-butanedione. 
FTFA, 4,4,4-trifluoro-O-(2-furyl)-1,3-butanedione. 
Protein concentration was 0.17 mg per assay. 
Volume 54, number 2 FEBS LETTERS June 1975 
Table 2 
The reversal of E. coli ATPase activity inhibited by bathophenanthroline with carbonyl 
cyanide-3-chlorophenyl hydrazone (CCCP) 
Strain 
Status 
of ATPase 
Bathophenanthroline CCCP ATPase activity 
(nmoles/assay) (nmoles/assay) (nmoles/mg prot./min) 
K12 W.T. Membrane- 0 0 1.0 
bound 0 14.4 0.8 
0 24.0 0.7 
0.03 0 0.7 
0.03 24.0 1.0 
0.09 0 0.5 
0.09 14.4 0.7 
0.09 24.0 0.9 
0.15 0 0.3 
0.15 24.0 0.6 
0.18 0 0.3 
0.18 14.4 0.9 
0.18 24.0 0.6 
AN293 Membrane- 0 0 1.0 
bound 0.15 0 0.6 
0.15 14.4 1.1 
AN293 Soluble 0 0 1.0 
0.15 0 1.1 
0.15 14.4 1.1 
AN293 Soluble 0 0 1.9 
trypsin 0.15 0 1.8 
treated 0.15 14.4 1.8 
AN259 Membrane- 0 0 1.0 
uncB+ bound 0.15 0 0.6 
0.27 0 0.5 
AN283 Membrane- 0 0 1.0 
uncB_ bound 0.15 0 0.9 
0.27 0 0.9 
Protein concentration was 0.185 mg for strain K12 W.T., 0.29 mg for strain AN293 membrane 
bound enzyme, 0.17 mg for strain AN293 soluble enzyme (both trypsin treated and untreated) and 
0.25 mg for both strain AN259 and AN283 per assay. 
inhibition is assumed to be a chelation of non-heme 
iron. 4,4,4-trifluoro-I-(Zfuryl)-l,3-butanedione 
(FTFA), an analog of TTFA is seen to inhibit mito- 
chondrial electron transport reactions in complexes 
I, II and III [ 191. The interference with non-heme 
iron sites by this inhibitor is also suggested. Since 
E. coli K12 membrane bound ATPase activity is 
inhibited by both TTFA and FTFA at a low level of 
these inhibitors we propose that a non-heme iron 
protein is a functional component in the energy 
coupling system. Bathophenanthroline does not 
inhibit the soluble ATPase both trypsin treated and 
untreated [ 15 ] as shown in table 2 in high Mg” 
buffer. In low Mg” a site for bathophenanthroline 
inhibition appears in the soluble enzyme whereas 
the membrane bound enzyme is less sensitive. 
Table 2 shows the bathophenanthroline inhibition 
of membrane bound ATPase activity is reversed by 
2.55 
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the uncoupler, CCCP. CCCP alone causes slight inhi- 
bition. With both CCCP and bathophenanthroline in 
the assay CCCP reverses the inhibition of bathophe- 
nanthroline. When bathophenanthroline concentration 
is low (0.03 pmol), 24 nmol of CCCP gives a complete 
reversal. With high bathophenanthroline concentration 
(0.15 pmol or 0.18 pmol), 24 nmol of CCCP gives 
only 60% reversal in the strain K12 wild type. This 
implies that there are several bathophenanthroline 
sensitive sites in the membrane sector; low bathophe- 
nanthroline inhibits primarily at those sites in the 
coupling region, at higher bathophenanthroline con- 
centration, the inhibition of other sites, not in the 
coupling region may become significant which are 
not CCCP reversible. The sensitivity to bathophenan- 
troline varies-in different strains. 40% inhibition is 
observed in the strain K12 wild type at 0.06 pmol 
bathophenantroline; but 0.15 gmol and 0.27 pmol 
is required for the same inhibition in strain AN293 
and AN259 respectively. AN283, an isogenic strain 
of AN2.59, deficient in uncB protein, is essentially 
insensitive to bathophenanthroline inhibition as 
shown in table 2. This indicates that the defect in 
uncB protein which is part of the membrane sector 
[20] somehow affects the response to bathophen- 
anthroline. Other uncouplers also reverse the batho- 
phenanthroline inhibition of ATPase as shown in 
table 3. Ionophores such as gramicidin, valinomycin 
and nigericin are essentially ineffective in reversing 
the bathophenanthroline inhibition of ATPase activi- 
ties. The lack of reversal of bathophenanthroline 
inhibition of electron transport activities by ionophores 
is also observed in mitochondria [lo]. Since ionophores 
which are known to prevent a proton gradient across 
the membrane do not bring the reversal of bathophen- 
anthroline inhibition, we suggest hat the ion gradients 
cannot be the primary step in energy transfer. 
The preformed ferrous-bathophenanthroline, shows 
no more than 10% inhibition of ATPase activity in both 
membrane-bound and solubilized form. CCCP does 
not induce an increase of activity. This lack or inhi- 
bition is in contrast to mitochondria where the chelate 
gives up to 70% inhibition of ATPase activity and 
CCCP causes up to 50% reversal compared to the 
reversal of bathophenanthroline inhibition [9]. A 
different mechanism of inhibition by ferrous-batho- 
phenanthroline is indicated in mitochondria which 
is missing in E. coli. The slight inhibition observed 
may be caused by a small amount of bathophenanthro- 
line which is dissociated from ferrous-bathophenanthro- 
line complex in the membrane. 
The inhibition by DCCD of soluble ATPase activi- 
ties at high concentration and membrane-bound 
ATPase activities at low concentration is shown in 
table 4. This is in contrast to Evan’s result [21] 
where he shows that the solubilized form of E. coli 
Table 3 
Prevention of bathophenanthroline inhibition of E. coli K12 membrane-bound ATPase activity by 
various uncoupling agents 
Uncoupling agents 
ATPase activity &moles Pi/mg prot./min) 
0 pmol Batho- 0.09 Hmol Batho- 0.15 rmol Batho- 
phenanthroline phenanthroline phenanthroline 
No uncoupling agent 
14.4 nmol CCCP 
3.1 nmol TTFB 
2.7 nmol S, 
2.5 nmol Pentachlorophenol 
1.9 nmol Dicumarol 
20 nmol Gramicidin + 100 @moles 
potassium acetate 
10 mol valinomycin + 14 pm01 
Nigericin + 100 pmol potassium 
1.0 0.5 0.3 
0.8 0.7 0.9 
0.9 0.9 0.9 
0.4 0.9 0.8 
1.0 0.8 0.1 
1.0 1.0 0.9 
0.8 0.5 0.3 
0.9 0.5 0.3 
Protein concentration was 0.185 mg per assay 
S, , 5-chloro-3-(p-chlorophenol)-4’-chlorosalicylanilide, CCCP, carbonyl cyanide-3-chlorophenyl 
hydrazone; TTFB, 4,5,6,7 tetrachloro-2-trifluoromethylbenzimidazole. 
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Table 4 
Effects of DCCD on ATPase activities of E. coli AN236 in the presence of CCCP, 
bathophenanthroline and both 
nmoles Batho- 
phenanthroline 
nmoles nmoles ATPase activity (nmoles Pi/mg prot/min) 
CCCP DCCD membrane-bound solubilized 
form form 
0 0 0 1.0 1.0 
0 0 5.0 0.5 1.0 
0 0 10.0 0.6 0.8 
0 24.0 5.0 0.5 
0 24.0 10.0 0.6 - 
0.03 0 0 0.7 .- 
0.09 0 0 0.6 - 
0.03 0 5.0 0.7 - 
0.09 0 5.0 0.6 _ 
0.03 24.0 0 1.0 - 
0.09 24.0 0 1.0 _ 
0.03 24.0 5.0 0.8 - 
0.09 24.0 5.0 0.8 _ 
Protein was 0.10 mg for soluble ATPase and 0.11 mg for membrane-bound ATPase per 
June 1975 
ATPase has higher sensitivity to DCCD than the 
membrane bound form. DCCD is a known inhibitor 
of mitochondrial membrane bound ATPase [22] 
which causes a non-specific inhibition with various 
protein functional groups such as COOH, try-OH, 
-NH*, -SH and Ser-OH [23-261. Since Evan applies 
a much higher DCCD concentration (5- 10 X 1 Oe5 
molar) than we do (2.5-5 X 10e6 molar), the 
inhibition of the soluble ATPase can be a non- 
specific inhibition due to greater exposure of protein 
functional groups. That CCCP does not reverse 
DCCD inhibition of ATPase activities, that batho- 
phenanthroline inhibition of ATPase activities is not 
reversed by DCCD and that DCCD inhibits ATPase 
activities reversed by CCCP in the presence of 
bathophenanthroline are also shown in table 4. Lower 
sensitivity of ATPase to DCCD inhibition in the 
presence of both CCCP and bathophenanthroline in 
comparison to DCCD alone may indicate a confor- 
mational change of ATPase complexes affected by 
CCCP and bathophenanthroline. 
Under low Mg” assay conditions the extent of 
inhibition of the membrane-bound ATPase is decreas- 
ed and a partial inhibition of the soluble ATPase 
appears. Under these conditions CCCP increases 
the extent of inhibition of the membrane bound 
enzyme and decreases the extent of inhibition of 
the soluble enzyme (table 5). A similar inhibition of 
the soluble mitochondrial ATPase by bathophe- 
nantroline and decrease in extent of inhibition in 
Table 5 
lnhibition of soluble and membrane-bound ATPase activity 
by bathophenanthroline and bathophenanthroline sulfonate 
under low M$+ assay conditions 
Enzyme 
state Inhibitor 
Percent inhibition 
11.5 mM Mg+* 2 mM Mg’+ 
Membrane- BP 0.09 nmol 
bound BP 0.1 S Hmol 
BP 0.1 S rmol 
+ CCCP 14 nmol 
Bps 0.12 Mmol 
Bps 0.6 bmol 
Soluble BP 0.18 nmol 
BP 0.18 Mmol 
+ CCCP 24 nmol 
Bps 0.12 nmol 
Bps 0.6 nmol 
50 17 
70 26 
10 41 
0 0 
0 -1 
0 21 
0 7 
- 20 
_ 34 
Bp: 4.7-Diphenyl-l.lO-phenanthroline. 
Bps: 4.7-Diphenyl-l.l~phenanthroline sulfonate. 
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the presence of uncouplers under low Mg” condi- 
tions has been reported by Phelps et al. [27]. We 
find, in contrast to the mitochondrial studies, 
that the soluble ATPase from E. coli is inhibited by 
the water soluble bathophenanthroline sulfonate 
at concentrations similar to bathophenanthroline 
(table 5) which indicates that detachment of the 
ATPase from the membrane may expose a chelator 
sensitive site. 
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